Centene Reports Strong Q1 Earnings, Raises Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy CNC?
Source: seekingalpha
- Earnings Beat: Centene's Q1 non-GAAP EPS of $3.37 exceeded expectations by $1.24, reflecting the company's ongoing success in managing medical costs and boosting investor confidence.
- Revenue Growth: The company reported Q1 revenue of $49.94 billion, a 7.1% year-over-year increase, surpassing market expectations by $2.39 billion, indicating strong performance in both Medicaid and Medicare segments.
- Guidance Increase: Centene raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, driven by optimism in Medicaid, despite consensus expectations of $188.8 billion.
- Updated Earnings Outlook: The company updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40, both exceeding the consensus of $3.02, indicating enhanced future profitability prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CNC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CNC
Wall Street analysts forecast CNC stock price to rise
15 Analyst Rating
5 Buy
8 Hold
2 Sell
Hold
Current: 41.820
Low
32.00
Averages
43.07
High
59.00
Current: 41.820
Low
32.00
Averages
43.07
High
59.00
About CNC
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Centene Scheduled to Announce Q1 Earnings on April 28
- Earnings Announcement: Centene (CNC) is set to release its Q1 2023 earnings report on April 28 before market open, with consensus EPS estimated at $2.13, reflecting a 26.6% year-over-year decline, while revenue is projected at $47.55 billion, representing a 2.0% year-over-year increase.
- Historical Performance: Over the past two years, Centene has exceeded EPS estimates 88% of the time and has beaten revenue estimates 100% of the time, indicating a strong track record of financial performance and reliability in meeting market expectations.
- Estimate Adjustments: In the last three months, EPS estimates have seen 7 upward revisions and 7 downward revisions, while revenue estimates have experienced 3 upward revisions and 5 downward revisions, reflecting market uncertainty and differing opinions on Centene's future performance.
- Market Reaction: Insurance stocks have surged due to the Medicare Advantage rate boost, with Humana and UnitedHealth leading the gains, indicating positive market sentiment towards the healthcare insurance sector, which may influence Centene's earnings report outcomes.
See More
Centene Reports Strong Q1 Earnings, Raises Guidance
- Earnings Beat: Centene's Q1 non-GAAP EPS of $3.37 exceeded expectations by $1.24, reflecting the company's ongoing success in managing medical costs and boosting investor confidence.
- Revenue Growth: The company reported Q1 revenue of $49.94 billion, a 7.1% year-over-year increase, surpassing market expectations by $2.39 billion, indicating strong performance in both Medicaid and Medicare segments.
- Guidance Increase: Centene raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, driven by optimism in Medicaid, despite consensus expectations of $188.8 billion.
- Updated Earnings Outlook: The company updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40, both exceeding the consensus of $3.02, indicating enhanced future profitability prospects.
See More
US Stocks Fluctuate Slightly, Tech Stocks Reach New All-Time Highs
- Tech Stock Surge: The S&P 500 and Nasdaq 100 indices rose by 0.12% and 0.01% respectively on Monday, reaching all-time highs, reflecting strong market optimism regarding AI infrastructure demand, which is expected to boost technology earnings.
- Oil Price Impact: WTI crude oil prices surged over 2%, exerting downward pressure on the market as President Trump canceled negotiations with Iran, raising inflation expectations that could affect the broader economic landscape.
- Rising Treasury Yields: The 10-year Treasury yield increased to 4.337% due to rising inflation expectations from higher oil prices, with markets anticipating the Fed will keep rates unchanged this week while awaiting further developments in oil prices and inflation.
- Health Insurance Stocks Rally: Health insurance stocks such as Centene, Elevance Health, and Humana all rose over 3% on Monday, providing support to the overall market and demonstrating resilience in the sector amid the current economic environment.
See More
Amazon and OpenAI Strategic Partnership Upgrade
- Microsoft Agreement Revision: The amended agreement between OpenAI and Microsoft allows OpenAI to offer all its products across any cloud provider, which is expected to positively impact Amazon Web Services (AWS), even though Amazon's stock showed little movement on the day after a 26% rise this month.
- Amazon CEO Commentary: Amazon CEO Andy Jassy expressed excitement about OpenAI's announcement on social media platform X, highlighting that the upcoming Stateful Runtime Environment will provide developers with more choices, further enhancing AWS's competitive edge in the market.
- Eli Lilly Acquires Ajax: Eli Lilly announced the acquisition of Ajax Therapeutics for up to $2.3 billion, with Ajax's lead asset being an investigational oral JAK2 inhibitor currently in Phase 1 trials, aimed at expanding Lilly's portfolio beyond GLP-1 drugs.
- Analyst Price Target Adjustment: Leerink maintained Eli Lilly's
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
Health Net Invests $10 Million to Accelerate Housing Development in Los Angeles
- Investment Amount: Health Net announced a $10 million investment in LA4LA's 'Guarantee Fund' aimed at accelerating the construction of affordable housing in Los Angeles County, which is expected to significantly shorten project startup times and meet urgent community housing needs.
- Housing Impact: This investment will support housing projects for various income levels, with up to 30% of units reserved for low-income families, which is anticipated to reduce homelessness and enhance community stability.
- Financing Facilitation: By providing guarantees, Health Net will assist lenders in offering larger loans, thereby promoting financing for more housing projects, particularly in communities near work centers and schools, enhancing residents' quality of life.
- Long-term Commitment: Since 2020, Health Net has invested $93 million in housing and homeless services, and this investment further demonstrates its long-term commitment to addressing California's housing crisis, expected to drive sustainable development in the region.
See More
Centene Scheduled to Announce Q1 Earnings on April 28
- Earnings Announcement: Centene (CNC) is set to release its Q1 2023 earnings report on April 28 before market open, with consensus EPS estimated at $2.13, reflecting a 26.6% year-over-year decline, while revenue is projected at $47.55 billion, representing a 2.0% year-over-year increase.
- Historical Performance: Over the past two years, Centene has exceeded EPS estimates 88% of the time and has beaten revenue estimates 100% of the time, indicating a strong track record of financial performance and reliability in meeting market expectations.
- Estimate Adjustments: In the last three months, EPS estimates have seen 7 upward revisions and 7 downward revisions, while revenue estimates have experienced 3 upward revisions and 5 downward revisions, reflecting market uncertainty and differing opinions on Centene's future performance.
- Market Reaction: Insurance stocks have surged due to the Medicare Advantage rate boost, with Humana and UnitedHealth leading the gains, indicating positive market sentiment towards the healthcare insurance sector, which may influence Centene's earnings report outcomes.
See More
Centene Reports Strong Q1 Earnings, Raises Guidance
- Earnings Beat: Centene's Q1 non-GAAP EPS of $3.37 exceeded expectations by $1.24, reflecting the company's ongoing success in managing medical costs and boosting investor confidence.
- Revenue Growth: The company reported Q1 revenue of $49.94 billion, a 7.1% year-over-year increase, surpassing market expectations by $2.39 billion, indicating strong performance in both Medicaid and Medicare segments.
- Guidance Increase: Centene raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, driven by optimism in Medicaid, despite consensus expectations of $188.8 billion.
- Updated Earnings Outlook: The company updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40, both exceeding the consensus of $3.02, indicating enhanced future profitability prospects.
See More
US Stocks Fluctuate Slightly, Tech Stocks Reach New All-Time Highs
- Tech Stock Surge: The S&P 500 and Nasdaq 100 indices rose by 0.12% and 0.01% respectively on Monday, reaching all-time highs, reflecting strong market optimism regarding AI infrastructure demand, which is expected to boost technology earnings.
- Oil Price Impact: WTI crude oil prices surged over 2%, exerting downward pressure on the market as President Trump canceled negotiations with Iran, raising inflation expectations that could affect the broader economic landscape.
- Rising Treasury Yields: The 10-year Treasury yield increased to 4.337% due to rising inflation expectations from higher oil prices, with markets anticipating the Fed will keep rates unchanged this week while awaiting further developments in oil prices and inflation.
- Health Insurance Stocks Rally: Health insurance stocks such as Centene, Elevance Health, and Humana all rose over 3% on Monday, providing support to the overall market and demonstrating resilience in the sector amid the current economic environment.
See More
Amazon and OpenAI Strategic Partnership Upgrade
- Microsoft Agreement Revision: The amended agreement between OpenAI and Microsoft allows OpenAI to offer all its products across any cloud provider, which is expected to positively impact Amazon Web Services (AWS), even though Amazon's stock showed little movement on the day after a 26% rise this month.
- Amazon CEO Commentary: Amazon CEO Andy Jassy expressed excitement about OpenAI's announcement on social media platform X, highlighting that the upcoming Stateful Runtime Environment will provide developers with more choices, further enhancing AWS's competitive edge in the market.
- Eli Lilly Acquires Ajax: Eli Lilly announced the acquisition of Ajax Therapeutics for up to $2.3 billion, with Ajax's lead asset being an investigational oral JAK2 inhibitor currently in Phase 1 trials, aimed at expanding Lilly's portfolio beyond GLP-1 drugs.
- Analyst Price Target Adjustment: Leerink maintained Eli Lilly's
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
Health Net Invests $10 Million to Accelerate Housing Development in Los Angeles
- Investment Amount: Health Net announced a $10 million investment in LA4LA's 'Guarantee Fund' aimed at accelerating the construction of affordable housing in Los Angeles County, which is expected to significantly shorten project startup times and meet urgent community housing needs.
- Housing Impact: This investment will support housing projects for various income levels, with up to 30% of units reserved for low-income families, which is anticipated to reduce homelessness and enhance community stability.
- Financing Facilitation: By providing guarantees, Health Net will assist lenders in offering larger loans, thereby promoting financing for more housing projects, particularly in communities near work centers and schools, enhancing residents' quality of life.
- Long-term Commitment: Since 2020, Health Net has invested $93 million in housing and homeless services, and this investment further demonstrates its long-term commitment to addressing California's housing crisis, expected to drive sustainable development in the region.
See More
